"Full service skin care clinic that specializes in providing the most effective, efficient, empathic, empowering care to give you the most skintastic experience. We see people of all ages with all skin concerns. We offer fellowship trained skin surgeons. We are a top 1% cosmetic injector in the country. We want to serve you and your skin in sickness and in health to keep you always looking and feeling skintastic. Check out our website to learn more information."

During the past decade, Johnson Dermatology conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 14 clinical trials were completed, i.e. on average, 56% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 12 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Johnson Dermatology" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Amgen" with 4 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "Cassiopea SpA" with 2 trials sponsored and "Concert Pharmaceuticals" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Johnson Dermatology" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "Dermira, Inc." with 2 trials as a collaborator, "Basilea Pharmaceutica" with 1 trials as a collaborator, "National Psoriasis Foundation" with 1 trials as a collaborator and "Patient-Centered Outcomes Research Institute" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Johnson Dermatology" are "Psoriasis" (7 trials), "Atopic Dermatitis" (5 trials), "Alopecia Areata" (4 trials), "Plaque Psoriasis" (4 trials) and "Acne Vulgaris" (2 trials). Many other conditions were trialed in "Johnson Dermatology" in a lesser frequency.

Most popular intervention types in "Johnson Dermatology" are "Drug" (21 trials), "Other" (5 trials), "Biological" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Apremilast" (3 trials), "Baricitinib" (3 trials), "BMS-986165" (2 trials) and "CB-03-01 cream, 1%" (2 trials). Other intervention names were less common.

The vast majority of trials in "Johnson Dermatology" are 26 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Johnson Dermatology". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 16 completed trials in Johnson Dermatology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Johnson Dermatology, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".